This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:cancer [03.13.2019] – [Marshall Protocol as a treatment for cancer?] sallieq | home:diseases:cancer [03.13.2019] – [Recent research] sallieq | ||
---|---|---|---|
Line 311: | Line 311: | ||
// | // | ||
</ | </ | ||
- | |||
- | |||
Line 325: | Line 323: | ||
</ | </ | ||
- | < | + | < |
+ | I found breast cancer in 1990, had a lumpectomy and follow up mastectomy with lymph node removal, as the cancer had begun to spread there. Similarly spreading, but in different organs, killed my mother at a slightly later stage of life. She had not sought treatment until too late. I have no doubt that prompt surgery and follow up radiotherapy and tamoxifen saved my life. At that period there were no alternatives or understanding of the microbiome. | ||
Interestingly, | Interestingly, | ||
Line 344: | Line 343: | ||
Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer. (({{pubmed> | Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer. (({{pubmed> | ||
+ | |||
+ | Olmesartan and Bay11-7082 inhibit the MCF-7 cells growth indicating RAS and NF-kappaB pathway blockade lead to cytotoxicity and apoptosis induction against tumour cells. So ARBs and NF-kappaB pathway inhibitors could be considered as anticancer drugs in future. | ||
+ | |||
+ | |||
+ | |||
+ | In this large population-based gastro-oesophageal cancer cohort, we found moderately reduced cancer-specific mortality among ARB users. However, confirmation in further independent epidemiological studies with sufficient staging information is required. | ||
Vitamin D and immune cells stimulate bone marrow disease (({{pubmed> | Vitamin D and immune cells stimulate bone marrow disease (({{pubmed> |